Literature DB >> 7905510

Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. Organ System Program, National Cancer Institute.

D F Deen1, A Chiarodo, E A Grimm, J R Fike, M A Israel, L E Kun, V A Levin, L J Marton, R J Packer, A E Pegg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7905510     DOI： 10.1007/bf01057041

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  85 in total

1.  Three-dimensional display in planning radiation therapy: a clinical perspective. Photon Treatment Planning Collaborative Working Group.

Authors: 
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

2.  Efficient tumor suppression by glioma-specific murine cytotoxic T lymphocytes transfected with interferon-gamma gene.

Authors:  S Miyatake; K Nishihara; H Kikuchi; J Yamashita; Y Namba; M Hanaoka; Y Watanabe
Journal:  J Natl Cancer Inst       Date:  1990-02-07       Impact factor: 13.506

3.  The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.

Authors:  A E Evans; R D Jenkin; R Sposto; J A Ortega; C B Wilson; W Wara; I J Ertel; S Kramer; C H Chang; S L Leikin
Journal:  J Neurosurg       Date:  1990-04       Impact factor: 5.115

4.  Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cGy dose level of Pediatric Oncology Group study #8495.

Authors:  C R Freeman; J Krischer; R A Sanford; M E Cohen; P C Burger; L Kun; E C Halperin; I Crocker; M Wharam
Journal:  Cancer       Date:  1991-08-01       Impact factor: 6.860

5.  A histological and flow cytometric study of dog brain endothelial cell injuries in delayed radiation necrosis.

Authors:  N Yamaguchi; T Yamashima; J Yamashita
Journal:  J Neurosurg       Date:  1991-04       Impact factor: 5.115

6.  Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and alpha-difluoromethylornithine.

Authors:  M Prados; L Rodriguez; M Chamberlain; P Silver; V Levin
Journal:  Neurosurgery       Date:  1989-06       Impact factor: 4.654

7.  Cerebellar medulloblastoma in adults.

Authors:  P G Hughes
Journal:  J Neurosurg       Date:  1984-05       Impact factor: 5.115

8.  Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy.

Authors:  B C Liang; A F Thornton; H M Sandler; H S Greenberg
Journal:  J Neurosurg       Date:  1991-10       Impact factor: 5.115

9.  Transforming growth factor-beta-like activity in tumors of the central nervous system.

Authors:  W C Clark; J Bressler
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

10.  Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease.

Authors:  P A Paganetti; P Caroni; M E Schwab
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539
View more
  11 in total

1.  Identification and functional characterization of glioma-specific promoters and their application in suicide gene therapy.

Authors:  Toshio Yawata; Yusuke Maeda; Makiko Okiku; Eri Ishida; Kazuhiro Ikenaka; Keiji Shimizu
Journal:  J Neurooncol       Date:  2011-02-24       Impact factor: 4.130

Review 2.  External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma.

Authors:  Neil K Taunk; Fabio Y Moraes; Freddy E Escorcia; Lucas Castro Mendez; Kathryn Beal; Gustavo N Marta
Journal:  Expert Rev Anticancer Ther       Date:  2016-02-09       Impact factor: 4.512

3.  Development of an in vitro extracellular matrix assay for studies of brain tumor cell invasion.

Authors:  A P Amar; S J DeArmond; D R Spencer; P F Coopersmith; D M Ramos; M L Rosenblum
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.

Authors:  M Weller; K Frei; P Groscurth; P H Krammer; Y Yonekawa; A Fontana
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

5.  Cellular plasticity regulated cancer stem cell niche: a possible new mechanism of chemoresistance.

Authors:  Marc Deheeger; Maciej S Lesniak; Atique U Ahmed
Journal:  Cancer Cell Microenviron       Date:  2014

6.  Targeting Subventricular Zone Progenitor Cells with Intraventricular Liposomal Encapsulated Cytarabine in Patients with Secondary Glioblastoma : A Report of Two Cases.

Authors:  Bruce M Frankel; David Cachia; Sunil J Patel; Arabinda Das
Journal:  SN Compr Clin Med       Date:  2020-05-23

7.  Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound.

Authors:  Feng-Yi Yang; Hsin-Ell Wang; Ren-Shyan Liu; Ming-Che Teng; Jia-Je Li; Maggie Lu; Ming-Cheng Wei; Tai-Tong Wong
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

8.  Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound.

Authors:  Feng-Yi Yang; Ming-Che Teng; Maggie Lu; Hsiang-Fa Liang; Yan-Ru Lee; Chueh-Chuan Yen; Muh-Lii Liang; Tai-Tong Wong
Journal:  Int J Nanomedicine       Date:  2012-02-21

9.  Current and Future Gene Therapy for Malignant Gliomas.

Authors:  Takao Kanzawa; Hideaki Ito; Yasuko Kondo; Seiji Kondo
Journal:  J Biomed Biotechnol       Date:  2003

Review 10.  Recurrent Glioblastoma: Where we stand.

Authors:  Sanjoy Roy; Debarshi Lahiri; Tapas Maji; Jaydip Biswas
Journal:  South Asian J Cancer       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.